Skip to content

Healing Abutment Materials on Matrix Metalloproteinase-8 Level in Peri-implant Crevicular Fluid

Effect of Two Different Healing Abutment Materials on Matrix Metalloproteinase-8 Level in Peri-implant Crevicular Fluid (a Randomised Clinical Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06034132
Enrollment
30
Registered
2023-09-13
Start date
2023-01-01
Completion date
2023-06-15
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implants

Brief summary

Numerous materials are nowadays used in the fabrication of healing abutments to be used for dental implants. soft tissue response to different healing abutment materials is still to be unraveled. the Aim of this study is to compare the soft tissue response to titanium stock healing abutments to customized composite healing abutments through assessing the level of matrix metalloproteinase-8 in the peri-implant crevicular fluid

Interventions

OTHERStock healing abutments

2ND stage surgery will be performed and stock healing abutment were placed

OTHERCompoiste healing abutments

2ND stage surgery will be performed and composite healing abutment were placed

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with no systemic and/or oral health disease * absence of any lesions in the oral cavity * wide band of keratinized tissue more than 1mm at implant site

Exclusion criteria

* smoking more than 20 cigarettes per day * localized radiation therapy of the oral cavity, * antitumor chemotherapy, liver diseases, blood diseases, kidney diseases, immunosuppressed patients, patients taking corticosteroids, pregnancy, inflammatory and autoimmune diseases of the oral cavity

Design outcomes

Primary

MeasureTime frameDescription
Change in MMP8 levelsat 2 weeks and 4 weeksMeasuring MMP-8 level around composite and titanium healing abutments with ELISA kit

Secondary

MeasureTime frameDescription
Change in gingival conditionat 2 weeks and 4 weeksModified gingival index was used to assess gingival condition The MGI uses a rating score between 0 and 4 0 = absence of inflammation 1. = mild inflammation 2. = mild inflammation 3. = moderate inflmmation 4. = severe inflammation
Change in gingival bleedingat 2 weeks and 4 weeksBleeding index will be recorded as present or absent
Change in plaque accumulationat 2 weeks and 4 weeksPlaque index 0: No plaque is in the area adjacent to the gingiva. Plaque index 1: There is a plaque in the form of a thin film on the gingival margin. Plaque index 2: There is a visible plaque in the gingival pocket and gingival margin. Plaque index 3: There is a dense plaque in the gingival pocket and on the gingival margin.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026